Tag: clinical trials

Using Dashboards and Heat Maps to Communicate Risk to Leadership

Posted on By digi

Using Dashboards and Heat Maps to Communicate Risk to Leadership Using Dashboards and Heat Maps to Communicate Risk to Leadership Introduction to Risk Communication in Clinical Trials Effective communication of risk within clinical trials is crucial for ensuring that leadership makes informed decisions. Clinical trials, such as the natalee clinical trial, often involve multiple complexities,…

Read More “Using Dashboards and Heat Maps to Communicate Risk to Leadership” »

Risk Assessment & Risk Controls

Handling Damaged, Lost or Mis-Labeled IP at the Site Level

Posted on By digi

<!– –> Handling Damaged, Lost or Mis-Labeled IP at the Site Level Handling Damaged, Lost or Mis-Labeled IP at the Site Level Clinical trials are intricate processes that require rigorous adherence to protocols, especially regarding investigational products (IP). One of the significant challenges that clinical site staff face is managing damaged, lost, or mis-labeled IP….

Read More “Handling Damaged, Lost or Mis-Labeled IP at the Site Level” »

IP/Device Accountability & Temperature Excursions

Blinding Considerations in IP and Device Accountability Processes

Posted on By digi

Blinding Considerations in IP and Device Accountability Processes Blinding Considerations in IP and Device Accountability Processes In the realm of clinical trials, particularly those aligned with precision medicine, the integrity of data is critical. The blinding of investigative products (IP) and devices is a substantial component of maintaining this integrity. This tutorial provides a comprehensive…

Read More “Blinding Considerations in IP and Device Accountability Processes” »

IP/Device Accountability & Temperature Excursions

Managing Country- and Site-Specific Documents in Global Trials

Posted on By digi

Managing Country- and Site-Specific Documents in Global Trials Managing Country- and Site-Specific Documents in Global Trials In the realm of global clinical trials, the management of country- and site-specific documents is critical. As regulatory requirements vary by region, each trial site may need to comply with local regulations beyond the overarching guidelines of organizations such…

Read More “Managing Country- and Site-Specific Documents in Global Trials” »

Essential Documents & TMF under GCP

Reconciliation Between CTMS, eTMF, IRT and Safety Systems

Posted on By digi

Reconciliation Between CTMS, eTMF, IRT and Safety Systems Reconciliation Between CTMS, eTMF, IRT and Safety Systems In the complex landscape of clinical trials, understanding the interplay between various systems such as Clinical Trial Management Systems (CTMS), electronic Trial Master Files (eTMF), Interactive Response Technology (IRT), and safety systems is vital. Each of these systems plays…

Read More “Reconciliation Between CTMS, eTMF, IRT and Safety Systems” »

Essential Documents & TMF under GCP

Risk Assessment Best Practices for Decentralized and Digital Trials

Posted on By digi

Risk Assessment Best Practices for Decentralized and Digital Trials Risk Assessment Best Practices for Decentralized and Digital Trials In the evolving landscape of clinical research, decentralized and digital trials are becoming increasingly prominent. These methodologies promise greater feasibility and patient engagement, yet they also introduce unique risks. This tutorial serves as a comprehensive guide to…

Read More “Risk Assessment Best Practices for Decentralized and Digital Trials” »

Risk Assessment & Risk Controls

Temperature Excursions: Detection, Assessment and Documentation

Posted on By digi

Temperature Excursions: Detection, Assessment and Documentation Temperature Excursions: Detection, Assessment and Documentation Temperature excursions during clinical trials are a critical concern for clinical operations professionals, regulatory affairs specialists, and medical affairs experts. These excursions can significantly impact the integrity of investigational products (IP), leading to unreliable data and non-compliance with good clinical practice (GCP) guidelines….

Read More “Temperature Excursions: Detection, Assessment and Documentation” »

IP/Device Accountability & Temperature Excursions

Using Temperature Monitoring Devices and Data Loggers Effectively

Posted on By digi

Using Temperature Monitoring Devices and Data Loggers Effectively Using Temperature Monitoring Devices and Data Loggers Effectively In clinical trials, adhering to good clinical practice (GCP) is essential to ensure the protection of trial participants, the integrity of data, and the validity of clinical outcomes. One critical aspect of GCP compliance involves temperature control of investigational…

Read More “Using Temperature Monitoring Devices and Data Loggers Effectively” »

IP/Device Accountability & Temperature Excursions

Defining Essential vs Non-Essential Documents in Complex Programs

Posted on By digi

Defining Essential vs Non-Essential Documents in Complex Programs The management of clinical trial documentation is paramount to the successful conduct of clinical research, particularly in complex programs. Understanding the differences between essential and non-essential documents not only helps streamline processes but also ensures compliance with regulatory standards set by authorities such as the FDA, EMA,…

Read More “Defining Essential vs Non-Essential Documents in Complex Programs” »

Essential Documents & TMF under GCP

TMF Completeness and Quality Metrics: What to Track and Why

Posted on By digi

TMF Completeness and Quality Metrics: What to Track and Why In the realm of clinical trial logistics, the Trial Master File (TMF) plays a vital role in ensuring the integrity, compliance, and success of clinical investigations. A comprehensive understanding of TMF completeness and quality metrics is essential for clinical operations, regulatory affairs, and medical affairs…

Read More “TMF Completeness and Quality Metrics: What to Track and Why” »

Essential Documents & TMF under GCP